Arkolith/Insider Trading/VAXX/Form 4

Diamandis Peter

DirectorVaxxinity, Inc. (VAXX) · full profile →Form 4 · filed May 2, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 26, 2023Option exercise(M)47K$1.21$56K906K
Apr 26, 2023Option exercise(M)429K$0.57$245K860K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 26, 2023Option exercise(M)47K—$0733K
Apr 26, 2023Option exercise(M)429K—$099K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-012008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML